Filament CSO Ryan Moss spoke to the Wall Street Journal about our development of standardized drug candidates made from psychedelics like magic mushrooms and ayahuasca.
Recent News
Drug Companies Join Medical Psychedelic Movement—but Without the High
The Wall Street Journal
December 18, 2022
.jpg)
